Olema Pharmaceuticals Inc (OLMA)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -23.22M | -27.22M | -29.6M | -21.6M | -23.34M | -30.42M | -34.34M | -33.53M |
税引前収入 | -22.72M | -26.18M | -28.29M | -20.1M | -21.5M | -26.77M | -30.97M | -30.38M |
純利益 | -22.72M | -26.18M | -28.29M | -20.1M | -21.5M | -26.77M | -30.97M | -30.38M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -23.32M | -27.15M | -29.59M | -21.65M | -23.42M | -30.32M | -34.32M | -33.49M |
EBITDA | -23.13M | -27.12M | -29.5M | -21.5M | -23.25M | -30.33M | -34.25M | -33.44M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -2.08M | -4.32M | -21.53M | -71.49M | -106.99M | -104.96M |
税引前収入 | -2.2M | -4.32M | -22.12M | -71.1M | -104.79M | -96.66M |
純利益 | -2.2M | -4.32M | -23.99M | -71.1M | -104.79M | -96.66M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.847 | -1.664 | -0.61 | -1.786 | -2.601 | -1.765 |
EBIT | -2.17M | -4.32M | -21.53M | -71.54M | -107.02M | -104.98M |
EBITDA | -2.07M | -4.31M | -21.52M | -71.33M | -106.63M | -104.58M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約